P-235 Isatuximab as Post-ASCT Therapy in MRDpositive Patients Augments CD8 Effector T Cell Differentiation: Insights from the UKMRA Phase 3 RADAR Study

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2024-09, Vol.24, p.S173-S174
Main Authors: Mehta, Dipal, Rahman, Jasmin, Lyon, Emma, Rees, Elise, Foster, Kane, Mikolajczak, Anna, Galas-Filipowicz, Daria, Olivier, Catherine, Barnard, Lorna, Royle, Kara-Louise, Cicero, Robert, Kennaway, Charlotte, Levinte, Doina, Clemmens, Jonathan, Parrish, Christopher, Drayson, Mark, Bygrave, Ceri, Smith, Dean, Pratt, Guy, Sive, Jonathan, Jenner, Matthew, Quezada, Sergio, Ramasamy, Karthik, Yong, Kwee
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/S2152-2650(24)02138-4